1804 terminated. 1804 Phase 2, 172 Phase 3, 159 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1804 | Terminated 1804 |
| Phase 3 | 172 | Terminated 172 |
| Phase 1 | 159 | Terminated 159 |
Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities VRB-101, Placebo - Obesity, Overweight | Phase 2 | Terminated | Verdiva Bio Dev Limited | 8 | 2026-06-12 | 2026-10-13 |
| Sex Differences in Neurobehavioral Response to THC Dronabinol, Placebo - Cannabis Use Disorder | Phase 2 | Terminated | Medical University of South Carolina | 5 | 2026-04-27 | 2026-10-06 |
| A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis Dupilumab, Placebo, IBI356 - Atopic Dermatitis | Phase 2 | Terminated | Innovent Biologics (Suzhou) Co. Ltd. | 18 | 2025-12-31 | 2026-10-27 |
| ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly ALXN2420, Placebo - Acromegaly | Phase 2 | Terminated | Alexion Pharmaceuticals, Inc. | 8 | 2025-10-28 | 2026-08-07 |
| Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection SNG001, Placebo - Viral Pneumonia | Phase 2 | Terminated | Synairgen Research Ltd. | 11 | 2025-09-02 | 2026-09-14 |
| A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis BGB-45035, Placebo - Rheumatoid Arthritis | Phase 2 | Terminated | BeiGene | 49 | 2025-08-21 | 2026-05-28 |
| A Study of K-645 in the Treatment of Multiple Migraine Attacks Placebo, K-645 dose level 1, K-645 dose level 2 - Acute Migraine | Phase 2 | Terminated | Kallyope Inc. | 134 | 2025-08-12 | 2025-11-25 |
| A Study of LY3549492 in Healthy Weight Adult Participants LY3549492, Placebo - Healthy | Phase 2 | Terminated | Eli Lilly and Company | 1 | 2025-07-21 | 2026-09-21 |
| A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients Ketamine Hydrochloride, Placebo - Depression | Phase 2 | Terminated | Mayo Clinic | 1 | 2025-07-07 | 2026-08-12 |
| A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes LY3549492, Placebo - Obesity, Overweight | Phase 2 | Terminated | Eli Lilly and Company | 1 | 2025-06-19 | 2026-08-31 |
| REGN5381 in Adult Participants With Uncontrolled Hypertension REGN5381, Placebo - Uncontrolled Hypertension | Phase 2 | Terminated | Regeneron Pharmaceuticals | 34 | 2025-04-16 | 2025-10-23 |
| A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease VENT-02, Placebo - Parkinson Disease | Phase 1 / Phase 2 | Terminated | Ventus Therapeutics U.S., Inc. | 29 | 2025-03-05 | 2025-10-29 |
| Study of the Oral Treatment MTR-601 in Cervical Dystonia MTR-601, Placebo - Cervical Dystonia | Phase 2 | Terminated | Motric Bio | 38 | 2025-02-28 | 2026-09-17 |
| A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) Dupilumab, JNJ-95475939, Placebo - Dermatitis, Atopic | Phase 2 | Terminated | Janssen Research & Development, LLC | 256 | 2025-02-26 | 2026-07-31 |
| A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE) GDC-8264, Placebo - Acute Kidney Injury | Phase 2 | Terminated | Genentech, Inc. | 67 | 2025-01-17 | 2026-03-16 |
| A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) Brensocatib, Placebo - Hidradenitis Suppurativa | Phase 2 | Terminated | Insmed Incorporated | 214 | 2024-12-16 | 2026-06-29 |
| A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) MK-1167, Placebo - Alzheimer Disease, Dementia | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 369 | 2024-12-16 | 2026-07-01 |
| Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS) Guanfacine Hydrochloride Immediate Release, Placebo - Hyperactivity in Children With Down Syndrome, Impulsivity in Children With Down Syndrome | Phase 2 | Terminated | Rachel G. Greenberg, MD, MB, MHS | 3 | 2024-12-09 | 2026-04-17 |
| A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder TMP-301, Placebo - Alcohol Use Disorder (AUD) | Phase 2 | Terminated | Tempero Bio, Inc. | 110 | 2024-11-14 | 2026-04-13 |
| A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1) BI 3720931, Placebo, Inhaler - Cystic Fibrosis | Phase 1 / Phase 2 | Terminated | Boehringer Ingelheim | 5 | 2024-11-04 | 2026-04-15 |
Showing 20 of 1804. Sign in to see all of them.
COVID-19 (108) · Alzheimer Disease (43) · Diabetes Mellitus, Type 2 (41) · Pain (37) · Asthma (35) · Arthritis, Rheumatoid (33) · Schizophrenia (32) · Heart Failure (31) · Breast Neoplasms (30) · Crohn Disease (30) · Colitis, Ulcerative (27) · Dermatitis, Atopic (27) · Inflammation (27) · Depression (26) · Diabetes Mellitus (26)
Novartis Pharmaceuticals (64) · Pfizer (56) · GlaxoSmithKline (32) · AstraZeneca (27) · Eli Lilly and Company (26) · Merck Sharp & Dohme LLC (26) · Janssen Research & Development, LLC (24) · Boehringer Ingelheim (20) · Bayer (18) · Mayo Clinic (17) · Hoffmann-La Roche (16) · Sanofi (16) · Amgen (15) · National Institute of Allergy and Infectious Diseases (NIAID) (15) · Biogen (13)
United States (1274) · Germany (317) · Canada (311) · Spain (283) · United Kingdom (278) · France (246) · Poland (229) · Italy (211) · Australia (168) · Belgium (161) · South Korea (135) · Japan (134) · Czechia (132) · Netherlands (130) · Hungary (107)
PMID 34473343, PMID 29515037, PMID 32031570, PMID 32171076, PMID 39903535, PMID 32734597, PMID 33687069, PMID 37528520, PMID 38299639, PMID 39952695, PMID 23053510, PMID 27208317, PMID 27789188, PMID 28433500, PMID 29282009, PMID 29480210, PMID 29990488, PMID 32250312, PMID 33307033, PMID 33675631, PMID 35244208, PMID 36418156, PMID 36750244, PMID 37345645, PMID 37494485, PMID 38010108, PMID 39356039, PMID 39462179, PMID 39637767, PMID 40603145, PMID 41388232, PMID 15618584, PMID 17478385, PMID 18006891, PMID 18164921, PMID 18413705, PMID 18565256, PMID 18827129, PMID 18946659, PMID 19092106, PMID 19117865, PMID 19238148, PMID 19460848, PMID 19585548, PMID 19734776, PMID 19910321, PMID 19958867, PMID 20297950, PMID 20363190, PMID 20463812
2023 (34), 2017 (32), 2018 (32), 2014 (28), 2016 (27), 2019 (27), 2009 (16), 2015 (16), 2008 (15), 2005 (7), P30CA015083 (3), N01CN00033 (2), P30CA014520 (2), P30CA016056 (2), P50DA009262 (2)